COUNTERPOINT: Routine Use of Autologous Stem Cell Transplantation in Multiple Myeloma – Cancer Network
Cancer Network |
COUNTERPOINT: Routine Use of Autologous Stem Cell Transplantation in Multiple Myeloma
Cancer Network Over the last decade, it has become clear that there are many different subsets of multiple myeloma, all with different biological drivers and a variety of patient-based characteristics that influence therapeutic efficacy.[1] Careful assessment of both … |
